PB2126: RETROSPECTIVE REAL LIFE STUDY OF MULTIPLE MYELOMA STATUS AT DEATH.

PB2126: RETROSPECTIVE REAL LIFE STUDY OF MULTIPLE MYELOMA STATUS AT DEATH.

Bibliographic Details
Main Authors:	Mónica Fernández Pérez, Ernesto Pérez Persona, Laura Salcedo Cuesta, Xabier Gutierrez Lopez De Ocariz, Jorge Illarramendi Esteban, , Beatriz Larrayoz Sola, Jose Maria Arguinano Perez
Format:	Article
Language:	English
Published:	Wiley 2023-08-01
Series:	HemaSphere
Online Access:	http://journals.lww.com/10.1097/01.HS9.0000975268.98644.32

Similar Items

PB2341: EARLY MORTALITY VARIABLES IN PATIENTS OLDER THAN 75 YEARS WITH DIFFUSE LARGE B-CELL LYMPHOMA
by: Mónica Fernández Pérez, et al.
Published: (2023-08-01)

PB2107: EVOLUTION OF SELECTION CRITERIA FOR PHASE 3 CLINICAL TRIALS IN MULTIPLE MYELOMA.
by: Ernesto Pérez, et al.
Published: (2023-08-01)

A first insight into Pycnoporus sanguineus BAFC 2126 transcriptome.
by: Cristian O Rohr, et al.
Published: (2013-01-01)

2126 Optimizing a technique for visualizing retinal and choroidal blood flow noninvasively
by: Paras Vora, et al.
Published: (2018-06-01)

PB2126: R-CPOP AS FIRST LINE TREATMENT FOR DLBCL PATIENTS WITH SIGNIFICANT REDUCED LVEF OR HIGH RISK OF ANTHRACYCLINE INDUCED CARDIOTOXICITY
by: K. Lorenz, et al.
Published: (2022-06-01)

Internet use and higher farmer participation in domestic waste sorting: micro-survey data from 2126 farming households in rural China
by: Fan Chen, et al.
Published: (2023-11-01)

Utility of Serum EB Virus Zta Antibody in the Diagnostic of Nasopharyngeal Carcinoma: Evidences From 2,126 Cases and 15,644 Controls
by: Guangying Zhang, et al.
Published: (2019-12-01)

2126 Saphenous vein graft atherosclerotic plaque quantification utilizing magnetic resonance imaging and multidetector computed tomography: a comparison with intravascular ultrasound
by: Zaman Azfar G, et al.
Published: (2008-10-01)

PB2153: IMPACT OF EXTRAMEDULLARY DISEASE IN PATIENTS WITH MULTIPLE MYELOMA: MULTICENTER RETROSPECTIVE ANALYSIS
by: Rita Costa e Sousa, et al.
Published: (2023-08-01)

Targeting Reactive Oxygen Species Metabolism to Induce Myeloma Cell Death
by: Mélody Caillot, et al.
Published: (2021-05-01)

PB2105: LENALIDOMIDE MAINTENANCE IN MULTIPLE MYELOMA: A RETROSPECTIVE, NATIONWIDE, REAL-WORLD STUDY
by: Mads Harsløf, et al.
Published: (2023-08-01)

PB2701: SAFETY OF 30 MINUTES INFUSION OF RITUXIMAB BIOSIMILAR. A COHORT STUDY.
by: Laida Cuevas Palomares, et al.
Published: (2023-08-01)

PB2081: CYTOGENETICS OF MULTIPLE MYELOMA IN MOROCCO
by: Yasmine Moutmir, et al.
Published: (2023-08-01)

Reações infusionais imediatas a agentes imunobiológicos endovenosos no tratamento de doenças autoimunes: experiência de 2.126 procedimentos em um centro de infusão não oncológico
by: Ingrid Bandeira Moss, et al.
Published: (2014-04-01)

PB2010: RETROSPECTIVE STUDY OF RELAPSED/REFRACTORY MYELOMA PATIENTS FROM AN INDIAN TERTIARY CENTRE: RESPONSE MATTERS!!
by: R. R. Lavu, et al.
Published: (2022-06-01)

PB1995: SAFETY OF SUBCUTANEOUS DARATUMUMAB IN MULTIPLE MYELOMA: A RETROSPECTIVE MULTI-CENTER REAL LIFE EXPERIENCE
by: D. De Novellis, et al.
Published: (2022-06-01)

A glimpse into relapsed refractory multiple myeloma treatment in real-world practice in Spain: the GeminiS study
by: Rafael Ríos-Tamayo, et al.
Published: (2023-12-01)

PB1961: ZNO NANOPARTICLES INDUCE MULTIPLE MYELOMA CELL DEATH BASED ON REACTIVE OXYGEN SPECIES AND CASPASE SIGNALING PATHWAY
by: Z. Li, et al.
Published: (2022-06-01)

PB2159: CHARACTERIZATION OF THE IMMUNE RESPONSE DEVELOPED IN PATIENTS WITH MULTIPLE MYELOMA AFTER RECEIVING TWO DOSES OF THE VACCINE AGAINST SARS-COV-2
by: Laura Perez, et al.
Published: (2023-08-01)

PB1970: AS2O3 INDUCE IMMUNOGENIC CELL DEATH IN MULTIPLE MYELOMA VIA NLRP3/CASPASE SIGNALING PATHWAY
by: Y. Si, et al.
Published: (2022-06-01)

PB1975: THE RESEARCH ON THE MECHANISM OF RRAD GENE IN MULTIPLE MYELOMA
by: C. Yi, et al.
Published: (2022-06-01)

PB1974: MULTIVARIATE SPECTRAL BIOTYPING OF EXTRAMEDULLARY MULTIPLE MYELOMA
by: M. Vlachová, et al.
Published: (2022-06-01)

PB2278: INVESTIGATION ON THE STATUS OF INFECTION IN PATIENTS WITH MULTIPLE MYELOMA
by: D. Lan, et al.
Published: (2022-06-01)

PB1990: MULTIPLE MYELOMA IN THE ELDERLY: A MONOCENTRIC EXPERIENCE
by: H. Charfi, et al.
Published: (2022-06-01)

PB1981: EFFICACY AND SAFETY OF DENOSUMAB IN PATIENTS WITH MULTIPLE MYELOMA
by: S. Bougherira, et al.
Published: (2022-06-01)

PB1969: FUNCTIONAL CHARACTERIZATION OF SUSCEPTIBILITY LOCI TO MULTIPLE MYELOMA
by: M. Shokouhi, et al.
Published: (2022-06-01)

Immunogenic Cell Death and Immunotherapy of Multiple Myeloma
by: Alfonso Serrano-del Valle, et al.
Published: (2019-04-01)

PB2432: MULTIPLE MYELOMA TRANSPLANT DATABASE IN PATIENTS OVER THE AGE OF 65: A SINGLE CENTRE RETROSPECTIVE COHORT ANALYSIS
by: Janet Tan, et al.
Published: (2023-08-01)

PB2319: ACQUIRED COAGULOPATHY: FACTOR X DEFICIENCY AT DIAGNOSIS OF MULTIPLE MYELOMA WITHOUT ASSOCIATED AMYLOIDOSIS
by: M. De La Torre De La Paz, et al.
Published: (2022-06-01)

PB2157: AUTOSCT IN PATIENTS WITH MULTIPLE MYELOMA AND DIALYSIS-DEPENDENT NEPHROPATHY
by: Ekaterina Karimova, et al.
Published: (2023-08-01)

PB2156: CLINICAL AND PROGNOSTIC FACTORS IN MULTIPLE MYELOMA IN THE GOMEL REGION
by: Zhanna Kozich, et al.
Published: (2023-08-01)

PB2086: SIMULTANEOUS DIAGNOSIS OF MULTIPLE MYELOMA AND MYELODYSPLASIA: CASE REPORT.
by: Khaled Benabed, et al.
Published: (2023-08-01)

PB1966: HEMOPOIETIC NICHE IMPAIRMENT IN TREATED MULTIPLE MYELOMA PATIENTS
by: N. Y. Semenova, et al.
Published: (2022-06-01)

PB2140: EVALUATION OF EARLY RELAPSE IN MULTIPLE MYELOMA (MM) PATIENTS
by: Annita-Ioanna Gkioka, et al.
Published: (2023-08-01)

Commentary: Immunogenic Cell Death and Immunotherapy of Multiple Myeloma
by: Ken Maes, et al.
Published: (2019-07-01)

PB2113: TREATMENT REFRACTORINESS AND RESPONSE RATES IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA: A RETROSPECTIVE ANALYSIS OF REAL-WORLD DATA
by: Zahra Majd, et al.
Published: (2023-08-01)

PB2091: DISPARITIES IN ENROLMENT INTO MULTIPLE MYELOMA CLINICAL TRIALS BY SOCIOECONOMIC DEPRIVATION
by: Amrutha Sridhar, et al.
Published: (2023-08-01)

PB2073: EVALUATION OF THE PLASMA METABOLOMIC PROFILE OF MGUS AND MULTIPLE MYELOMA PATIENTS
by: Klaudia Ciesluk, et al.
Published: (2023-08-01)

PB2145: IMPACT OF A SIZE OF BONE PLASMACYTOMA ON THE COURSE OF MULTIPLE MYELOMA
by: Elizaveta Mamaeva, et al.
Published: (2023-08-01)

PB2096: SELINEXOR COMBINED REGIMEN FOR MULTIPLE MYELOMA WITH EXTRAMEDULLARY DISEASE(EMD)
by: Yuping Zhong, et al.
Published: (2023-08-01)